Imatinib Completed Phase N/A Trials for All Indications for Glivec/Gleevec and Tasigna

IndicationsStatusPurposePhase
CompletedNot AvailableNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT01289054A Global Imatinib and Nilotinib Pregnancy Exposure Registry